M. J. García Sánchez

Carbamazepine population pharmacokinetics in children: mixed-effect models.

A. Falcão, M. Otero, M. F. Delgado Iribarnegaray, 1997, Therapeutic drug monitoring.

The Convergence of Therapeutic Drug Monitoring and Pharmacogenetic Testing to Optimize Efavirenz Therapy

M. J. García Sánchez, A. Domínguez-Gil Hurlé, S. C. Cabrera Figueroa, 2010, Therapeutic drug monitoring.

Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients.

Á. Carracedo, M. J. García Sánchez, A. Domínguez-Gil Hurlé, 2014, Personalized medicine.

Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients.

J. Hernández-Rivas, M. L. Sayalero Marinero, M. F. D. Fernández de Gatta, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Population Pharmacokinetics of Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients

A. Hurlé, D. S. Buelga, M. J. García Sánchez, 2011, Therapeutic drug monitoring.

Valproate population pharmacokinetics in children

A. Domínguez-Gil, M. Otero, D. S. Buelga, 1999, Journal of clinical pharmacy and therapeutics.

[New strategies in the optimisation of lopinavir/ritonavir doses in human immunodeficiency virus-infected patients].

M. G. Sánchez, M. J. García Sánchez, Elena López Aspiroz, 2013, Enfermedades infecciosas y microbiologia clinica.